Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,116

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,793

Class I recallsReasonable probability of serious health consequences

24,343

Class II recallsTemporary or medically reversible health consequences

2,887

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,072 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/saratoga-potato-chips-issues-allergy-alert-undeclared-soy-j-higgs-loaded-bacon-and-cheddar-potatoPublished September 16, 2026

Most affected stateHawaii 200 recalls mention this state

State: AS ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated September 18, 2026 ET

Summary (Year to date)

1,527 recalls have been announced year to date.
Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
The highest complete period was Jun 2026 (297).
Sep 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,343
Class I	9,793
Class III	2,887
Not Yet Classified	1

Download CSV

Recalls by class
Class	Recalls
Class II	24,343
Class I	9,793
Class III	2,887
Not Yet Classified	1

FDA Recall Terminated Historical recordClass III

Lovastatin Tablets USP, 40 mg, packaged in a) 60-count (NDC 68180-469-07 and b) 100-count (NDC 68180-469-01) bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Goa 403 722 INDIA.

by Lupin Pharmaceuticals Inc.

Reason: CGMP Deviations: Finished product made with lovastatin drug substance that was out of specification for individual impurity results.
Published: February 27, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Ciclopirox shampoo 1%,120 mL bottle, Rx only, Manufactured By Perrigo Bronx, NY 10457 Distributed by Perrigo Allegan, MI 49010, 45802-401-09

by Perrigo New York, Inc.

Reason: Failed Degradation/Impurities Specifications: Out of specification related substance results during stability testing.
Published: February 27, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Moisturizing Lubricant Eye Drops, 0.25% Sodium Carboxymethylcellulose, 0.5 Fl OZ (15mL) Distributed by: Walgreen Co, 200 Wilmont Rd Deerfield IL 60015 NDC 00363-9651-01.

by Akorn Inc

Reason: Failed Stability Specification: out of specification results for Sodium Perborate
Published: February 27, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

0.9% Sodium Chloride Injection, USP 1000 mL flexible container, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-7983-09

by ICU Medical Inc

Reason: CGMP Deviations
Published: February 27, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Ephedrine Sulfate, 50 mg/10 mL, 10 mL Single Use Syringe, Rx only, US Compounding Pharmacy 1270 Don's Lane Conway, AR 800-718-3588, Barcode: 62295308407

by US Compounding Inc

Reason: Lack of assurance of sterility.
Published: February 27, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Divalproex Sodium Extended-release Tablets, USP 250 mg, 100-count bottle, Rx only, Mfd.By: Dr. Reddy's Laboratories Limited Bachupally - 500 090 India NDC 55111-533-01

by Dr. Reddy's Laboratories, Inc.

Reason: Failed Dissolution Specifications: Out of specification results observed for high dissolution.
Published: February 27, 2019
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

LOSARTAN POTASSIUM and HYDROCHLOROTHIAZIDE TABLETS, USP 50 mg/12.5 mg, a) 90-count bottle (NDC: 13668-116-90), b) 1000-count bottle (NDC: 13668-116-10), Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana Inda

by Torrent Pharma Inc.

Reason: CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.
Published: February 27, 2019
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

LOSARTAN POTASSIUM and HYDROCHLOROTHIAZIDE TABLETS, USP, 100 mg/12.5 mg, a) 90-count bottle (NDC: 13668-117-90), b) 1000-count bottle (NDC: 13668-117-10), Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana Inda

by Torrent Pharma Inc.

Reason: CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.
Published: February 27, 2019
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

LOSARTAN POTASSIUM TABLETS, USP, 25 mg, 90-count bottle (NDC: 13668-113-90), Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana Inda

by Torrent Pharma Inc.

Reason: CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.
Published: February 27, 2019
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

LOSARTAN POTASSIUM TABLETS, USP, 50 mg, a) 30-count bottle (NDC: 13668-409-30), b) 90-count bottle (NDC: 13668-409-90), c) 1000-count bottle (NDC: 13668-409-10), Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana Inda

by Torrent Pharma Inc.

Reason: CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.
Published: February 27, 2019
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

LOSARTAN POTASSIUM TABLETS, USP, 100 mg, a) 30-count (NDC: 13668-115-30), b) 90-count (NDC: 13668-115-90), c) 1000-count (NDC: 13668-115-10) per bottle, Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana Inda

by Torrent Pharma Inc.

Reason: CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.
Published: February 27, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Oxytocin 30 Units added to NS 500 mL (oxytocin and 0.9% Sodium Chloride) Injectable Solution, Approximately 503 mL Sterile single use bag, Rx only, Avella of Houston, 9265 Kirby Dr., Houston, TX 77054, NDC 42852-706-50.

by Advanced Pharma Inc.

Reason: Superpotent Drug: product may contain concentrations of oxytocin higher than what is represented on the label.
Published: February 27, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Oxytocin 20 Units added to NS 1000 mL (oxytocin and 0.9% Sodium Chloride) Injectable Solution, Approximately 1002 mL Sterile single use bag, Rx only, Avella of Houston, 9265 Kirby Dr., Houston, TX 77054, NDC 42852-703-99.

by Advanced Pharma Inc.

Reason: Superpotent Drug: product may contain concentrations of oxytocin higher than what is represented on the label.
Published: February 27, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Oxytocin 10 Units added to NS 1000 mL (oxytocin and 0.9% Sodium Chloride) Injectable Solution, Approximately 1001 mL Sterile single use bag, Rx only, Avella of Houston, 9265 Kirby Dr., Houston, TX 77054, NDC 42852-730-99.

by Advanced Pharma Inc.

Reason: Superpotent Drug: product may contain concentrations of oxytocin higher than what is represented on the label.
Published: February 27, 2019
Distribution: Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

Ardent Mills, LLC

Product: MEMBERS MARK SELF RISE FLR 25LB
Reason: Ardent Mills is voluntarily recalling certain lots of Self-Rising Flour because it has the potential to be contaminated with Salmonella.
Published: February 27, 2019
Distribution: Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

Ardent Mills, LLC

Product: WESTCREEK H&R SELF RISE AP FLR 25LB and 50LB
Reason: Ardent Mills is voluntarily recalling certain lots of Self-Rising Flour because it has the potential to be contaminated with Salmonella.
Published: February 27, 2019
Distribution: Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

Ardent Mills, LLC

Product: HILLTOP HEARTH SELF RISE FLR 25LB and 50LB
Reason: Ardent Mills is voluntarily recalling certain lots of Self-Rising Flour because it has the potential to be contaminated with Salmonella.
Published: February 27, 2019
Distribution: Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

Ardent Mills, LLC

Product: ARDENT H&R SR FLR, 25LB, 50 LB, and 25LB (PC)-309951, packag…
Reason: Ardent Mills is voluntarily recalling certain lots of Self-Rising Flour because it has the potential to be contaminated with Salmonella.
Published: February 27, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Levetiracetam in 0.54 % Sodium Chloride Injection 1,500/mg/100mL (15mg/mL), For intravenous Infusion Only, 1 x 100 mL Infusion bag, Manufactured by: Gland Pharma Limited Hyderabad - 500 043, India Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 UPC 343598637525 ---- NDC 43598-637-52

by Dr. Reddy's Laboratories, Inc.

Reason: Labeling: Label Error on Declared Strength; the pre-printed text on the primary infusion bag and the NDC incorrectly identifies the product as Levetiracetam in 0.75% Sodium Chloride (1000 mg/100 mL) however, the external foil pouch correctly identifies the product as Levetiracetam in 0.54% Sodium Chloride Injection (1,500/100 mL).
Published: February 20, 2019
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Glutathione Injection, 200 mg/mL, 10 mL, Rx Only, Promise Pharmacy Compounding Specialists 31818 US Hwy 19N, Palm Harbor, FL 34684

by Promise Pharmacy, LLC

Reason: Lack of sterility assurance.
Published: February 20, 2019
Distribution: Nationwide

View recall →

Data last updated: September 18, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.